Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT05473195
What this trial is testing

Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098

Who this might be right for
Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
TASK Applied Science 105
Post-approval studies (Phase 4)Study completedNCT02231229
What this trial is testing

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Who this might be right for
Tuberculosis
Assistance Publique - Hôpitaux de Paris 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT06526039
What this trial is testing

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Who this might be right for
Tuberculosis, Pulmonary
Taipei Medical University WanFang Hospital 100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation